Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Advances in Therapy|December 10, 2015
Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung CancerLisa M Hess, Narayan Rajan, Katherine Winfree, et al.
Clinical Lung Cancer|June 3, 2017
Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and JapanD Christian Fenske, Gregory L Price, Lisa M Hess, et al.
The Patient|January 20, 2019
Patient and Oncologist Preferences for the Treatment of Adults with Advanced Soft Tissue Sarcoma: A Discrete Choice ExperimentJasmina Ivanova, Lisa M Hess, Viviana Garcia-Horton, et al.
Clinical Sarcoma Research|May 11, 2018
Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomasRohan C Parikh, Maria Lorenzo, Lisa M Hess, et al.
JMIR Cancer|June 11, 2025
Next-Generation Sequencing-Based Testing Among Patients With Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States: Predictive Modeling Using Machine Learning MethodsAlan James Michael Brnabic, Ilya Lipkovich, Zbigniew Kadziola, et al.
Journal of Medical Economics|May 24, 2017
Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040Lisa M Hess, Zhanglin Lin Cui, Yixun Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
What happened to the coxibs on the way to the cardiologist?David S Alberts, John D Potter, Maria Elena Martinez, et al.
Applied Health Economics and Health Policy|June 29, 2010
Oncologist preferences for health states associated with the treatment of advanced ovarian cancerLisa M Hess, Daniel C Malone, Grant H Skrepnek, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2015
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.SGayathri Kumar, Beth Woods, Lisa M Hess, et al.
Journal of Medical Economics|April 21, 2018
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United StatesLisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Advances in Therapy|December 10, 2015
Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung CancerLisa M Hess, Narayan Rajan, Katherine Winfree, et al.
Clinical Lung Cancer|June 3, 2017
Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and JapanD Christian Fenske, Gregory L Price, Lisa M Hess, et al.
The Patient|January 20, 2019
Patient and Oncologist Preferences for the Treatment of Adults with Advanced Soft Tissue Sarcoma: A Discrete Choice ExperimentJasmina Ivanova, Lisa M Hess, Viviana Garcia-Horton, et al.
Clinical Sarcoma Research|May 11, 2018
Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomasRohan C Parikh, Maria Lorenzo, Lisa M Hess, et al.
JMIR Cancer|June 11, 2025
Next-Generation Sequencing-Based Testing Among Patients With Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States: Predictive Modeling Using Machine Learning MethodsAlan James Michael Brnabic, Ilya Lipkovich, Zbigniew Kadziola, et al.
Journal of Medical Economics|May 24, 2017
Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040Lisa M Hess, Zhanglin Lin Cui, Yixun Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
What happened to the coxibs on the way to the cardiologist?David S Alberts, John D Potter, Maria Elena Martinez, et al.
Applied Health Economics and Health Policy|June 29, 2010
Oncologist preferences for health states associated with the treatment of advanced ovarian cancerLisa M Hess, Daniel C Malone, Grant H Skrepnek, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2015
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.SGayathri Kumar, Beth Woods, Lisa M Hess, et al.
Journal of Medical Economics|April 21, 2018
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United StatesLisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, et al.
Pageof 11